Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome
Laboratory Medicine · 2025
DOI: 10.1093/labmed/lmaf033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Soon Hee Chang. Beteiligte Einrichtung: Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Myeloproliferative Disorders, Blood Platelets, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Institutional Review Board of Kyungpook National University Hospital.
Abstract (Originalsprache)
Introduction
Platelet parameters are inexpensive and readily available biomarkers for platelet activation. This study investigated the differences and usefulness of platelet parameters in myeloproliferative neoplasms (MPNs), immune-mediated thrombocytopenia, and myelodysplastic syndrome (MDS), which are major hematologic disorders associated with platelet activation or dysfunction.
Methods
We enrolled 418 patients: 186 with MPN, 109 with immune-mediated thrombocytopenia, and 123 with MDS. Platelet count and platelet parameters, including mean platelet volume (MPV), platelet distribution width (PDW), plateletcrit, and mean platelet component (MPC), were measured using an automated hematology analyzer.
Results
Platelet parameters, particularly MPV and MPC, showed statistically significant differences in MPN compared with healthy control individuals, indicating the most significant platelet activation in primary myelofibrosis. We noted that MPV, plateletcrit, and MPC differed substantially between immune thrombocytopenic purpura and aplastic anemia compared with healthy control individuals, with statistically significant differences in MPV, PDW, and MPC between immune thrombocytopenic purpura and aplastic anemia. All parameters revealed statistically significant differences between MDS and healthy controls.
Discussion
Platelet parameters demonstrated significant differences among patients with MPN, immune-mediated thrombocytopenia, and MDS compared with healthy control individuals, suggesting platelet activation in these disorders. They may also be useful markers for differentiating the causative disease in patients with thrombocytosis or thrombocytopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Korea.
ORCID-Profile: Soon Hee Chang
Förderung
- Institutional Review Board of Kyungpook National University Hospital
Zitieren
APA
Chang, S. H. (2025). Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome. Laboratory Medicine. https://doi.org/10.1093/labmed/lmaf033
Vancouver
Chang SH. Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome. Laboratory Medicine. 2025. doi:10.1093/labmed/lmaf033
BibTeX
@article{Chang2025,
author = {Chang, Soon Hee},
title = {Platelet parameters and their role in myeloproliferative neoplasms, immune-mediated thrombocytopenia, and myelodysplastic syndrome},
journal = {Laboratory Medicine},
year = {2025},
doi = {10.1093/labmed/lmaf033}
}
EUVIMED